• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经移植旁输注胰岛素-肝素可显著提高单次供者临床胰岛移植的成功率。

Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success.

机构信息

1 Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada. 2 Division of Clinical Immunology, Department of Oncology, Radiology and Clinical Immunology, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.

出版信息

Transplantation. 2010 Feb 27;89(4):465-71. doi: 10.1097/TP.0b013e3181c478fd.

DOI:10.1097/TP.0b013e3181c478fd
PMID:20177350
Abstract

BACKGROUND

Successful islet transplantation can result in insulin independence in many patients with type 1 diabetes mellitus, but it often requires more than one islet infusion. The ability to achieve insulin independence with a single donor is an important goal in clinical islet transplantation due to the limited organ supply.

METHODS

We examined factors that may be associated with insulin independence after islet transplantation with islets from a single donor, using univariate and multivariate analysis.

RESULTS

Thirteen of 85 (15.3%) achieved insulin independence after single-donor islet transplantation. Using multivariate analysis, only the use of insulin and heparin infusions peritransplant was a significant factor associated with insulin independence, with an adjusted odds ratio of 8.6 (95% confidence interval 2.0-37.0). Patients who had received insulin and heparin infusions peritransplant had greater indices of islet engraftment and a greater reduction in insulin use (80.1% + or - 4.3% vs. 54.2% + or - 2.8%, P<0.001) even if insulin independence was not achieved.

CONCLUSIONS

Peritransplant intensive insulin and heparin enhances islet transplantation outcomes likely related in part to mitigation of the effects of the instant blood-mediated inflammatory reaction, combined with islet rest and avoidance of inflammation. It would be important to further investigate the effects of peritransplant insulin and heparin infusions on islet engraftment.

摘要

背景

成功的胰岛移植可以使许多 1 型糖尿病患者实现胰岛素独立性,但通常需要输注不止一次胰岛。由于供体器官有限,实现单次供体胰岛移植后胰岛素独立性是临床胰岛移植的一个重要目标。

方法

我们使用单变量和多变量分析来检查与单次供体胰岛移植后胰岛素独立性相关的因素。

结果

在 85 名患者中,有 13 名(15.3%)在接受单次供体胰岛移植后实现了胰岛素独立性。使用多变量分析,只有移植期间使用胰岛素和肝素输注是与胰岛素独立性相关的显著因素,调整后的优势比为 8.6(95%置信区间 2.0-37.0)。接受移植期间胰岛素和肝素输注的患者胰岛移植的植入指数更高,胰岛素使用量减少更多(80.1%+或-4.3%比 54.2%+或-2.8%,P<0.001),即使没有实现胰岛素独立性。

结论

移植期间强化胰岛素和肝素可能会增强胰岛移植的效果,这可能部分与减轻即时血液介导的炎症反应的影响有关,同时还可以使胰岛得到休息和避免炎症。进一步研究移植期间胰岛素和肝素输注对胰岛植入的影响非常重要。

相似文献

1
Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success.经移植旁输注胰岛素-肝素可显著提高单次供者临床胰岛移植的成功率。
Transplantation. 2010 Feb 27;89(4):465-71. doi: 10.1097/TP.0b013e3181c478fd.
2
Insulin independence of unstable diabetic patient after single living donor islet transplantation.单例活体供体胰岛移植后不稳定糖尿病患者实现胰岛素非依赖状态
Transplant Proc. 2005 Oct;37(8):3427-9. doi: 10.1016/j.transproceed.2005.09.044.
3
Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.改进人类胰岛分离方法,用于一项关于1型糖尿病胰岛移植与最佳药物治疗的前瞻性队列研究。
Arch Surg. 2005 Aug;140(8):735-44. doi: 10.1001/archsurg.140.8.735.
4
Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation.通过胰岛移植对象的分泌单位对活体供体和尸体供体新鲜或培养胰岛移植进行植入的简单评估。
Transplant Proc. 2005 Oct;37(8):3435-7. doi: 10.1016/j.transproceed.2005.09.045.
5
Evaluation of engraftment after single islet transplantation from a brain-dead donor by the secretory unit of islet transplant objects (SUITO) index.通过胰岛移植对象分泌单位(SUITO)指数评估脑死亡供体单胰岛移植后的植入情况。
Transplant Proc. 2008 Mar;40(2):364-6. doi: 10.1016/j.transproceed.2007.12.023.
6
Clinical islet transplantation at the University of Alberta--the Edmonton experience.阿尔伯塔大学的临床胰岛移植——埃德蒙顿经验。
Clin Transpl. 2005:153-72.
7
C-peptide and glucose values in the peritransplant period after intraportal islet infusions in type 1 diabetes.1型糖尿病患者门静脉内输注胰岛后移植期的C肽和葡萄糖值。
Transplant Proc. 2005 Oct;37(8):3433-4. doi: 10.1016/j.transproceed.2005.09.090.
8
Islet cell transplantation for Type 1 diabetes.胰岛细胞移植治疗 1 型糖尿病。
J Diabetes. 2010 Mar;2(1):16-22. doi: 10.1111/j.1753-0407.2009.00048.x. Epub 2009 Aug 17.
9
Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.利用远程隔离中心通过胰岛移植实现胰岛素自主分泌:第一年回顾
Transplant Proc. 2004 May;36(4):1127-9. doi: 10.1016/j.transproceed.2004.04.057.
10
Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.艾塞那肽对1型糖尿病胰岛移植后β细胞功能的影响。
Transplantation. 2007 Jan 15;83(1):24-8. doi: 10.1097/01.tp.0000251379.46596.2d.

引用本文的文献

1
Assessing Implantation Sites for Pancreatic Islet Cell Transplantation: Implications for Type 1 Diabetes Mellitus Treatment.评估胰岛细胞移植的植入部位:对1型糖尿病治疗的意义。
Bioengineering (Basel). 2025 May 9;12(5):499. doi: 10.3390/bioengineering12050499.
2
Status of islet transplantation and innovations to sustainable outcomes: novel sites, cell sources, and drug delivery strategies.胰岛移植现状及实现可持续成果的创新:新位点、细胞来源和药物递送策略
Front Transplant. 2024 Nov 1;3:1485444. doi: 10.3389/frtra.2024.1485444. eCollection 2024.
3
Perioperative Management of Patients Undergoing Total Pancreatectomy with/without Islet Cell Autotransplantation: A Single Center Experience.
接受全胰切除术伴或不伴胰岛细胞自体移植患者的围手术期管理:单中心经验
J Clin Med. 2023 Jun 12;12(12):3993. doi: 10.3390/jcm12123993.
4
Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients.载有低组织因子的新型细胞疗法 NestaCell® 不会增加重症 COVID-19 肝素治疗患者的血栓形成风险。
Biomed Pharmacother. 2022 May;149:112920. doi: 10.1016/j.biopha.2022.112920. Epub 2022 Apr 1.
5
Estimation of Early Graft Function Using the BETA-2 Score Following Clinical Islet Transplantation.临床胰岛移植后使用 BETA-2 评分估计早期移植物功能。
Transpl Int. 2022 Jul 6;35:10335. doi: 10.3389/ti.2022.10335. eCollection 2022.
6
Effects of different routes of heparin on instant blood-mediated inflammatory reaction after portal vein islet transplantation.不同肝素给药途径对门静脉胰岛移植后即时血介导炎症反应的影响。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jan 28;47(1):1-7. doi: 10.11817/j.issn.1672-7347.2022.200993.
7
The Influence of Microenvironment on Survival of Intraportal Transplanted Islets.微环境对门静脉内移植胰岛存活的影响。
Front Immunol. 2022 Mar 28;13:849580. doi: 10.3389/fimmu.2022.849580. eCollection 2022.
8
Bioenergetics of Islet Preparations in a Pilot Clinical Trial of Peri-Transplant Hydroxychloroquine for Autologous Islet Transplantation.胰岛制剂的生物能量学:自体胰岛移植围手术期羟氯喹治疗的初步临床试验。
Cell Transplant. 2021 Jan-Dec;30:9636897211057440. doi: 10.1177/09636897211057440.
9
Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes.胰岛移植治疗糖尿病的进展。
Front Endocrinol (Lausanne). 2021 Sep 13;12:732431. doi: 10.3389/fendo.2021.732431. eCollection 2021.
10
Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review.糖尿病合并终末期肾病患者的移植选择:综述。
Am J Kidney Dis. 2021 Sep;78(3):418-428. doi: 10.1053/j.ajkd.2021.02.339. Epub 2021 May 14.